1. Home
  2. THH vs PRTA Comparison

THH vs PRTA Comparison

Compare THH & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THH
  • PRTA
  • Stock Information
  • Founded
  • THH 2013
  • PRTA 2012
  • Country
  • THH Japan
  • PRTA Ireland
  • Employees
  • THH N/A
  • PRTA N/A
  • Industry
  • THH
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • THH
  • PRTA Health Care
  • Exchange
  • THH Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • THH 414.9M
  • PRTA 472.1M
  • IPO Year
  • THH 2025
  • PRTA N/A
  • Fundamental
  • Price
  • THH $9.81
  • PRTA $10.50
  • Analyst Decision
  • THH
  • PRTA Buy
  • Analyst Count
  • THH 0
  • PRTA 9
  • Target Price
  • THH N/A
  • PRTA $17.71
  • AVG Volume (30 Days)
  • THH 49.2K
  • PRTA 613.0K
  • Earning Date
  • THH 12-05-2025
  • PRTA 11-06-2025
  • Dividend Yield
  • THH N/A
  • PRTA N/A
  • EPS Growth
  • THH N/A
  • PRTA N/A
  • EPS
  • THH 0.00
  • PRTA N/A
  • Revenue
  • THH $24,528,835.00
  • PRTA $11,786,000.00
  • Revenue This Year
  • THH N/A
  • PRTA N/A
  • Revenue Next Year
  • THH N/A
  • PRTA $672.02
  • P/E Ratio
  • THH $4,864.29
  • PRTA N/A
  • Revenue Growth
  • THH 2.24
  • PRTA N/A
  • 52 Week Low
  • THH $4.20
  • PRTA $4.32
  • 52 Week High
  • THH $12.00
  • PRTA $17.66
  • Technical
  • Relative Strength Index (RSI)
  • THH N/A
  • PRTA 54.50
  • Support Level
  • THH N/A
  • PRTA $9.90
  • Resistance Level
  • THH N/A
  • PRTA $10.91
  • Average True Range (ATR)
  • THH 0.00
  • PRTA 0.60
  • MACD
  • THH 0.00
  • PRTA -0.03
  • Stochastic Oscillator
  • THH 0.00
  • PRTA 56.94

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a Japan-based lifestyle entertainment company offering services across the entertainment and hospitality sectors. Its main businesses include event curation, consultancy and management, sub-leasing of venues, and restaurant operations. The company operates through four segments, with the majority of revenue generated from consultancy and management, which provides club planning, operations, event production, entertainer bookings, and sponsorship services. The event curation segment produces both in-house and client events; the sub-leasing segment rents venues and sub-leases them to clubs; and the restaurants segment operates themed dining outlets that complement its entertainment offerings.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: